Department of Endocrinology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland.
Department of Nephrology, Transplantology and Internal Diseases, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
BMC Nephrol. 2022 Mar 3;23(1):85. doi: 10.1186/s12882-022-02714-w.
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease. Defect in cilia-mediated signaling activity is a crucial factor leading to cyst formation. Hence, ADPKD is regarded as a systemic disorder with multiple extrarenal complications, including cysts in other organs, for instance, the liver, pancreas, spleen, or ovaries. Interestingly, loss-of-function of primary cilia has been recently found to contribute to a malignant transformation from degenerated thyroid follicles. However, the increased incidence of thyroid nodules in ADPKD patients has not yet been fully confirmed.
To determine the incidence of thyroid lesions in patients with ADPKD in comparison to previous population studies. Moreover, we aimed to investigate if the pace of the disease progression is associated with a higher prevalence of thyroid lesions.
In 49 early-stage ADPKD patients recruited from our center, we performed ultrasonography of the thyroid glands, and laboratory evaluation of thyroids function. We compared the results with population studies.
Twenty-three individuals had solid, cystic-solid, or cystic lesions revealed in the ultrasonography and 2 patients had a positive past medical history for thyroidectomy due to nodular goiter. In 10 patients out of the 23, only minor cysts with no clinical significance were found and 13 out of the 23 patients had solid or cystic-solid lesions, which occurred to be benign based on three years of follow-up or the biopsy of the nodule.
We found no increased incidence of thyroid gland lesions in early ADPKD patients in comparison to previous population studies. Plausibly, mechanisms other than defective cilia signaling are involved in the risk for focal thyroid lesions formation. Moreover, the rate of progression of kidney function decline seems to be not accompanied by the higher incidence of thyroid pathology.
常染色体显性多囊肾病(ADPKD)是最常见的遗传性肾脏疾病。纤毛介导的信号活性缺陷是导致囊肿形成的关键因素。因此,ADPKD被认为是一种全身性疾病,伴有多种肾脏外并发症,包括其他器官的囊肿,例如肝、胰腺、脾或卵巢。有趣的是,最近发现原发性纤毛丧失功能有助于退化的甲状腺滤泡发生恶性转化。然而,ADPKD 患者甲状腺结节的发病率增加尚未得到充分证实。
与以前的人群研究相比,确定 ADPKD 患者甲状腺病变的发生率。此外,我们旨在研究疾病进展速度是否与更高的甲状腺病变患病率相关。
在我们中心招募的 49 名早期 ADPKD 患者中,我们对甲状腺进行超声检查,并进行甲状腺功能的实验室评估。我们将结果与人群研究进行比较。
23 名患者的超声检查显示实性、囊实性或囊性病变,2 名患者因结节性甲状腺肿有甲状腺切除术的阳性既往病史。在 23 名患者中的 10 名中,仅发现无临床意义的小囊肿,在 23 名患者中的 13 名中发现实性或囊实性病变,基于三年随访或结节活检,这些病变被认为是良性的。
与以前的人群研究相比,我们未发现早期 ADPKD 患者甲状腺病变的发生率增加。可能除了纤毛信号缺陷机制外,其他机制也参与了局灶性甲状腺病变形成的风险。此外,肾功能下降的进展速度似乎不会伴有更高的甲状腺病理学发生率。